APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gene Therapy

Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.

Selected research

Market Structure

Global Gene Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025198 pages

Choose your research edition.

Industry ResearchGene Therapy Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Gene Therapy Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Gene Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gene Therapy Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Gene Therapy Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.

Global Gene Therapy key players include Biogen, Novartis, Gilead Sciences, etc. Global top three manufacturers hold a share about 75%.

North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific, both have a share about 35 percent.

Read the full market overview

In terms of product, Non-viral Gene Therapy is the largest segment, with a share about 55%. And in terms of application, the largest application is Neurological Diseases, followed by Cancer.

Report Includes

This report provides an overview of the global Gene Therapy market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gene Therapy and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gene Therapy revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Gene Therapy market size, projected growth trends, production technologies, key applications, and end-use industries.

Gene Therapy Segment by Company

Biogen

Novartis

Gilead Sciences

Sarepta Therapeutics

Alnylam Pharmaceuticals

Amgen

Spark Therapeutics

Akcea Therapeutics

bluebird bio

Sunway Biotech

SIBIONO

AnGes

Orchard Therapeutics

Human Stem Cells Institute

Gene Therapy Segment by Type

Viral Gene Therapy

Non-Viral Gene Therapy

Gene Therapy Segment by Application

Neurological Diseases

Cancer

Other

Gene Therapy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gene Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Gene Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gene Therapy industry.

Chapter 3: Detailed analysis of Gene Therapy companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gene Therapyrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Gene Therapy Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Viral Gene Therapy Table 3. Key Players of Non-Viral Gene Therapy Table 4. Global Gene Therapy Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Neurological Diseases Table 6. Key Players of Cancer Table 7. Key Players of Other Table 8. Global Gene Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Gene Therapy Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Gene Therapy Market Share by Region (2021-2026) Table 11. Global Gene Therapy Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Gene Therapy Market Share by Region (2027-2032) Table 13. Gene Therapy Industry Trends Table 14. Gene Therapy Industry Drivers Table 15. Gene Therapy Industry Opportunities and Challenges Table 16. Gene Therapy Industry Restraints Table 17. Global Gene Therapy Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Gene Therapy Revenue Market Share by Company (2021-2026) Table 19. Global Gene Therapy Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Gene Therapy Key Company Head Office and Area Served Table 21. Global Gene Therapy Company, Product Type & Application Table 22. Global Gene Therapy Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Gene Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Gene Therapy Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Gene Therapy Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Gene Therapy Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Gene Therapy Revenue Market Share by Type (2021-2026) Table 29. Global Gene Therapy Revenue Market Share by Type (2027-2032) Table 30. Global Gene Therapy Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Gene Therapy Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Gene Therapy Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Gene Therapy Revenue Market Share by Application (2021-2026) Table 34. Global Gene Therapy Revenue Market Share by Application (2027-2032) Table 35. Biogen Company Information Table 36. Biogen Business Overview Table 37. Biogen Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Biogen Gene Therapy Product Portfolio Table 39. Biogen Recent Development Table 40. Novartis Company Information Table 41. Novartis Business Overview Table 42. Novartis Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Novartis Gene Therapy Product Portfolio Table 44. Novartis Recent Development Table 45. Gilead Sciences Company Information Table 46. Gilead Sciences Business Overview Table 47. Gilead Sciences Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Gilead Sciences Gene Therapy Product Portfolio Table 49. Gilead Sciences Recent Development Table 50. Sarepta Therapeutics Company Information Table 51. Sarepta Therapeutics Business Overview Table 52. Sarepta Therapeutics Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Sarepta Therapeutics Gene Therapy Product Portfolio Table 54. Sarepta Therapeutics Recent Development Table 55. Alnylam Pharmaceuticals Company Information Table 56. Alnylam Pharmaceuticals Business Overview Table 57. Alnylam Pharmaceuticals Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Alnylam Pharmaceuticals Gene Therapy Product Portfolio Table 59. Alnylam Pharmaceuticals Recent Development Table 60. Amgen Company Information Table 61. Amgen Business Overview Table 62. Amgen Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Amgen Gene Therapy Product Portfolio Table 64. Amgen Recent Development Table 65. Spark Therapeutics Company Information Table 66. Spark Therapeutics Business Overview Table 67. Spark Therapeutics Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Spark Therapeutics Gene Therapy Product Portfolio Table 69. Spark Therapeutics Recent Development Table 70. Akcea Therapeutics Company Information Table 71. Akcea Therapeutics Business Overview Table 72. Akcea Therapeutics Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Akcea Therapeutics Gene Therapy Product Portfolio Table 74. Akcea Therapeutics Recent Development Table 75. bluebird bio Company Information Table 76. bluebird bio Business Overview Table 77. bluebird bio Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. bluebird bio Gene Therapy Product Portfolio Table 79. bluebird bio Recent Development Table 80. Sunway Biotech Company Information Table 81. Sunway Biotech Business Overview Table 82. Sunway Biotech Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Sunway Biotech Gene Therapy Product Portfolio Table 84. Sunway Biotech Recent Development Table 85. SIBIONO Company Information Table 86. SIBIONO Business Overview Table 87. SIBIONO Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. SIBIONO Gene Therapy Product Portfolio Table 89. SIBIONO Recent Development Table 90. AnGes Company Information Table 91. AnGes Business Overview Table 92. AnGes Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. AnGes Gene Therapy Product Portfolio Table 94. AnGes Recent Development Table 95. Orchard Therapeutics Company Information Table 96. Orchard Therapeutics Business Overview Table 97. Orchard Therapeutics Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. Orchard Therapeutics Gene Therapy Product Portfolio Table 99. Orchard Therapeutics Recent Development Table 100. Human Stem Cells Institute Company Information Table 101. Human Stem Cells Institute Business Overview Table 102. Human Stem Cells Institute Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. Human Stem Cells Institute Gene Therapy Product Portfolio Table 104. Human Stem Cells Institute Recent Development Table 105. North America Gene Therapy Market Size by Type (2021-2026) & (US$ Million) Table 106. North America Gene Therapy Market Size by Type (2027-2032) & (US$ Million) Table 107. North America Gene Therapy Market Size by Application (2021-2026) & (US$ Million) Table 108. North America Gene Therapy Market Size by Application (2027-2032) & (US$ Million) Table 109. North America Gene Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. North America Gene Therapy Market Size by Country (2021-2026) Table 111. North America Gene Therapy Market Size by Country (2027-2032) Table 112. Europe Gene Therapy Market Size by Type (2021-2026) & (US$ Million) Table 113. Europe Gene Therapy Market Size by Type (2027-2032) & (US$ Million) Table 114. Europe Gene Therapy Market Size by Application (2021-2026) & (US$ Million) Table 115. Europe Gene Therapy Market Size by Application (2027-2032) & (US$ Million) Table 116. Europe Gene Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. Europe Gene Therapy Market Size by Country (2021-2026) Table 118. Europe Gene Therapy Market Size by Country (2027-2032) Table 119. China Gene Therapy Market Size by Type (2021-2026) & (US$ Million) Table 120. China Gene Therapy Market Size by Type (2027-2032) & (US$ Million) Table 121. China Gene Therapy Market Size by Application (2021-2026) & (US$ Million) Table 122. China Gene Therapy Market Size by Application (2027-2032) & (US$ Million) Table 123. Asia Gene Therapy Market Size by Type (2021-2026) & (US$ Million) Table 124. Asia Gene Therapy Market Size by Type (2027-2032) & (US$ Million) Table 125. Asia Gene Therapy Market Size by Application (2021-2026) & (US$ Million) Table 126. Asia Gene Therapy Market Size by Application (2027-2032) & (US$ Million) Table 127. Asia Gene Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Asia Gene Therapy Market Size by Country (2021-2026) Table 129. Asia Gene Therapy Market Size by Country (2027-2032) Table 130. South America, Middle East & Africa Gene Therapy Market Size by Type (2021-2026) & (US$ Million) Table 131. South America, Middle East & Africa Gene Therapy Market Size by Type (2027-2032) & (US$ Million) Table 132. South America, Middle East & Africa Gene Therapy Market Size by Application (2021-2026) & (US$ Million) Table 133. South America, Middle East & Africa Gene Therapy Market Size by Application (2027-2032) & (US$ Million) Table 134. South America, Middle East & Africa Gene Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. South America, Middle East & Africa Gene Therapy Market Size by Country (2021-2026) Table 136. South America, Middle East & Africa Gene Therapy Market Size by Country (2027-2032) Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Gene Therapy Product Image Figure 2. Global Gene Therapy Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Gene Therapy Market Share by Type: 2025 VS 2032 Figure 4. Viral Gene Therapy Image Figure 5. Non-Viral Gene Therapy Image Figure 6. Global Gene Therapy Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Gene Therapy Market Share by Application: 2025 VS 2032 Figure 8. Neurological Diseases Image Figure 9. Cancer Image Figure 10. Other Image Figure 11. Global Gene Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 13. Global Gene Therapy Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Gene Therapy Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Gene Therapy Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Gene Therapy Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Gene Therapy Revenue Market Share by Type (2021-2032) Figure 20. Global Gene Therapy Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Gene Therapy Revenue Market Share by Application (2021-2032) Figure 22. North America Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 23. North America Gene Therapy Market Share by Type (2021-2032) Figure 24. North America Gene Therapy Market Share by Application (2021-2032) Figure 25. North America Gene Therapy Market Share by Country (2021-2032) Figure 26. United States Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 27. Canada Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 29. Europe Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 30. Europe Gene Therapy Market Share by Type (2021-2032) Figure 31. Europe Gene Therapy Market Share by Application (2021-2032) Figure 32. Europe Gene Therapy Market Share by Country (2021-2032) Figure 33. Germany Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 34. France Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 36. Italy Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 37. Russia Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 39. China Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 40. China Gene Therapy Market Share by Type (2021-2032) Figure 41. China Gene Therapy Market Share by Application (2021-2032) Figure 42. Asia Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 43. Asia Gene Therapy Market Share by Type (2021-2032) Figure 44. Asia Gene Therapy Market Share by Application (2021-2032) Figure 45. Asia Gene Therapy Market Share by Country (2021-2032) Figure 46. Japan Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 50. India Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 51. Australia Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Gene Therapy Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Gene Therapy Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Gene Therapy Market Share by Country (2021-2032) Figure 56. Brazil Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 61. UAE Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 63. Chile Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Viral Gene Therapy
  • Non-Viral Gene Therapy
Applications
  • Neurological Diseases
  • Cancer
  • Other
Companies covered
  • Biogen
  • Novartis
  • Gilead Sciences
  • Sarepta Therapeutics
  • Alnylam Pharmaceuticals
  • Amgen
  • Spark Therapeutics
  • Akcea Therapeutics
  • bluebird bio
  • Sunway Biotech
  • SIBIONO
  • AnGes
  • Orchard Therapeutics
  • Human Stem Cells Institute

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Gene Therapy Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Viral Gene Therapy
  5. 1.2.3 Non-Viral Gene Therapy
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Gene Therapy Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Neurological Diseases
  9. 1.3.3 Cancer
  10. 1.3.4 Other
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Gene Therapy Growth Trends by Region
  13. 1.5.1 Global Gene Therapy Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Gene Therapy Market Size by Region (2021-2026)
  15. 1.5.3 Gene Therapy Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Gene Therapy Market Dynamics
  1. 2.1 Gene Therapy Industry Trends
  2. 2.2 Gene Therapy Industry Drivers
  3. 2.3 Gene Therapy Industry Opportunities and Challenges
  4. 2.4 Gene Therapy Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Gene Therapy Revenue by Company (2021-2026)
  2. 3.2 Global Gene Therapy Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Gene Therapy Key Company Head office and Area Served
  4. 3.4 Global Gene Therapy Company, Product Type & Application
  5. 3.5 Global Gene Therapy Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Gene Therapy Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Gene Therapy Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Gene Therapy Tier 1, Tier 2, and Tier 3
4 Gene Therapy Market by Type
  1. 4.1 Global Gene Therapy Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Gene Therapy Market Size by Type (2021-2032)
  3. 4.3 Global Gene Therapy Market Size Share by Type (2021-2032)
5 Gene Therapy Market by Application
  1. 5.1 Global Gene Therapy Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Gene Therapy Market Size by Application (2021-2032)
  3. 5.3 Global Gene Therapy Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Biogen
  2. 6.1.1 Biogen Company Information
  3. 6.1.2 Biogen Business Overview
  4. 6.1.3 Biogen Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Biogen Gene Therapy Product Portfolio
  6. 6.1.5 Biogen Recent Developments
  7. 6.2 Novartis
  8. 6.2.1 Novartis Company Information
  9. 6.2.2 Novartis Business Overview
  10. 6.2.3 Novartis Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Novartis Gene Therapy Product Portfolio
  12. 6.2.5 Novartis Recent Developments
  13. 6.3 Gilead Sciences
  14. 6.3.1 Gilead Sciences Company Information
  15. 6.3.2 Gilead Sciences Business Overview
  16. 6.3.3 Gilead Sciences Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Gilead Sciences Gene Therapy Product Portfolio
  18. 6.3.5 Gilead Sciences Recent Developments
  19. 6.4 Sarepta Therapeutics
  20. 6.4.1 Sarepta Therapeutics Company Information
  21. 6.4.2 Sarepta Therapeutics Business Overview
  22. 6.4.3 Sarepta Therapeutics Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Sarepta Therapeutics Gene Therapy Product Portfolio
  24. 6.4.5 Sarepta Therapeutics Recent Developments
  25. 6.5 Alnylam Pharmaceuticals
  26. 6.5.1 Alnylam Pharmaceuticals Company Information
  27. 6.5.2 Alnylam Pharmaceuticals Business Overview
  28. 6.5.3 Alnylam Pharmaceuticals Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Alnylam Pharmaceuticals Gene Therapy Product Portfolio
  30. 6.5.5 Alnylam Pharmaceuticals Recent Developments
  31. 6.6 Amgen
  32. 6.6.1 Amgen Company Information
  33. 6.6.2 Amgen Business Overview
  34. 6.6.3 Amgen Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Amgen Gene Therapy Product Portfolio
  36. 6.6.5 Amgen Recent Developments
  37. 6.7 Spark Therapeutics
  38. 6.7.1 Spark Therapeutics Company Information
  39. 6.7.2 Spark Therapeutics Business Overview
  40. 6.7.3 Spark Therapeutics Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Spark Therapeutics Gene Therapy Product Portfolio
  42. 6.7.5 Spark Therapeutics Recent Developments
  43. 6.8 Akcea Therapeutics
  44. 6.8.1 Akcea Therapeutics Company Information
  45. 6.8.2 Akcea Therapeutics Business Overview
  46. 6.8.3 Akcea Therapeutics Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Akcea Therapeutics Gene Therapy Product Portfolio
  48. 6.8.5 Akcea Therapeutics Recent Developments
  49. 6.9 bluebird bio
  50. 6.9.1 bluebird bio Company Information
  51. 6.9.2 bluebird bio Business Overview
  52. 6.9.3 bluebird bio Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 bluebird bio Gene Therapy Product Portfolio
  54. 6.9.5 bluebird bio Recent Developments
  55. 6.10 Sunway Biotech
  56. 6.10.1 Sunway Biotech Company Information
  57. 6.10.2 Sunway Biotech Business Overview
  58. 6.10.3 Sunway Biotech Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Sunway Biotech Gene Therapy Product Portfolio
  60. 6.10.5 Sunway Biotech Recent Developments
  61. 6.11 SIBIONO
  62. 6.11.1 SIBIONO Company Information
  63. 6.11.2 SIBIONO Business Overview
  64. 6.11.3 SIBIONO Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 SIBIONO Gene Therapy Product Portfolio
  66. 6.11.5 SIBIONO Recent Developments
  67. 6.12 AnGes
  68. 6.12.1 AnGes Company Information
  69. 6.12.2 AnGes Business Overview
  70. 6.12.3 AnGes Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 AnGes Gene Therapy Product Portfolio
  72. 6.12.5 AnGes Recent Developments
  73. 6.13 Orchard Therapeutics
  74. 6.13.1 Orchard Therapeutics Company Information
  75. 6.13.2 Orchard Therapeutics Business Overview
  76. 6.13.3 Orchard Therapeutics Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Orchard Therapeutics Gene Therapy Product Portfolio
  78. 6.13.5 Orchard Therapeutics Recent Developments
  79. 6.14 Human Stem Cells Institute
  80. 6.14.1 Human Stem Cells Institute Company Information
  81. 6.14.2 Human Stem Cells Institute Business Overview
  82. 6.14.3 Human Stem Cells Institute Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Human Stem Cells Institute Gene Therapy Product Portfolio
  84. 6.14.5 Human Stem Cells Institute Recent Developments
7 North America
  1. 7.1 North America Gene Therapy Market Size (2021-2032)
  2. 7.2 North America Gene Therapy Market Size by Type
  3. 7.2.1 North America Gene Therapy Market Size by Type (2021-2026)
  4. 7.2.2 North America Gene Therapy Market Size by Type (2027-2032)
  5. 7.2.3 North America Gene Therapy Market Share by Type (2021-2032)
  6. 7.3 North America Gene Therapy Market Size by Application
  7. 7.3.1 North America Gene Therapy Market Size by Application (2021-2026)
  8. 7.3.2 North America Gene Therapy Market Size by Application (2027-2032)
  9. 7.3.3 North America Gene Therapy Market Share by Application (2021-2032)
  10. 7.4 North America Gene Therapy Market Size by Country
  11. 7.4.1 North America Gene Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Gene Therapy Market Size by Country (2021-2026)
  13. 7.4.3 North America Gene Therapy Market Size by Country (2027-2032)
  14. 7.4.4 North America Gene Therapy Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Gene Therapy Market Size (2021-2032)
  2. 8.2 Europe Gene Therapy Market Size by Type
  3. 8.2.1 Europe Gene Therapy Market Size by Type (2021-2026)
  4. 8.2.2 Europe Gene Therapy Market Size by Type (2027-2032)
  5. 8.2.3 Europe Gene Therapy Market Share by Type (2021-2032)
  6. 8.3 Europe Gene Therapy Market Size by Application
  7. 8.3.1 Europe Gene Therapy Market Size by Application (2021-2026)
  8. 8.3.2 Europe Gene Therapy Market Size by Application (2027-2032)
  9. 8.3.3 Europe Gene Therapy Market Share by Application (2021-2032)
  10. 8.4 Europe Gene Therapy Market Size by Country
  11. 8.4.1 Europe Gene Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Gene Therapy Market Size by Country (2021-2026)
  13. 8.4.3 Europe Gene Therapy Market Size by Country (2027-2032)
  14. 8.4.4 Europe Gene Therapy Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Gene Therapy Market Size (2021-2032)
  2. 9.2 China Gene Therapy Market Size by Type
  3. 9.2.1 China Gene Therapy Market Size by Type (2021-2026)
  4. 9.2.2 China Gene Therapy Market Size by Type (2027-2032)
  5. 9.2.3 China Gene Therapy Market Share by Type (2021-2032)
  6. 9.3 China Gene Therapy Market Size by Application
  7. 9.3.1 China Gene Therapy Market Size by Application (2021-2026)
  8. 9.3.2 China Gene Therapy Market Size by Application (2027-2032)
  9. 9.3.3 China Gene Therapy Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Gene Therapy Market Size (2021-2032)
  2. 10.2 Asia Gene Therapy Market Size by Type
  3. 10.2.1 Asia Gene Therapy Market Size by Type (2021-2026)
  4. 10.2.2 Asia Gene Therapy Market Size by Type (2027-2032)
  5. 10.2.3 Asia Gene Therapy Market Share by Type (2021-2032)
  6. 10.3 Asia Gene Therapy Market Size by Application
  7. 10.3.1 Asia Gene Therapy Market Size by Application (2021-2026)
  8. 10.3.2 Asia Gene Therapy Market Size by Application (2027-2032)
  9. 10.3.3 Asia Gene Therapy Market Share by Application (2021-2032)
  10. 10.4 Asia Gene Therapy Market Size by Country
  11. 10.4.1 Asia Gene Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Gene Therapy Market Size by Country (2021-2026)
  13. 10.4.3 Asia Gene Therapy Market Size by Country (2027-2032)
  14. 10.4.4 Asia Gene Therapy Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Gene Therapy Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Gene Therapy Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Gene Therapy Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Gene Therapy Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Gene Therapy Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Gene Therapy Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Gene Therapy Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Gene Therapy Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Gene Therapy Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Gene Therapy Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Gene Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Gene Therapy Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Gene Therapy Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Gene Therapy Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst